Diffusion Pharmaceuticals Inc expected to post a loss of $2.06 a share - Earnings Preview

CervoMed

04/11/2022 19:41

* Diffusion Pharmaceuticals Inc  DFFN.OQ   DFFN.O  is
expected
to show no change in quarterly revenue when it reports 
results on November 8 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for Diffusion
Pharmaceuticals
Inc is for a loss of $2.06 per share. 
    * The one available analyst rating on the shares is "buy".  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Diffusion
Pharmaceuticals Inc is $24.75​, above​ its last closing price
of $4.99. ​​​

This summary was machine generated November 4 at 19:40 GMT.  All
figures in US dollars  unless otherwise stated